CVS Health Corp

Healthcare · Healthcare Plans

85.70$ -1.6% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

CVS Health Corp (CVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 261,064 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CVS
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	5,694	5,979	6,686	7,275	7,950	8,636	9,645	10,543	14,547	15,283	20,574	54,722	60,960	61,641	62,169	64,543	66,221	71,526	74,187	92,437	94,462	95,131	196,456	222,449	230,715	232,999	228,275	249,728	253,215	261,064
Current Assets	3,529	3,892	4,349	4,608	4,937	5,410	5,982	6,497	7,920	8,393	10,396	14,149	16,526	17,537	17,706	18,594	20,161	25,325	25,983	29,158	31,042	31,229	45,243	50,302	56,369	60,008	65,633	67,858	68,645	74,714
Cash	472	193	181	230	337	236	700	843	392	513	531	1,057	1,352	1,086	1,427	1,413	1,375	4,089	2,481	2,459	3,371	1,696	4,059	5,683	7,854	9,408	12,945	8,196	8,586	8,512
Cash & Short-Term Investments	472	193	181	230	337	236	700	843	392	513	531	1,084	1,352	1,091	1,431	1,418	1,380	4,177	2,515	2,547	3,458	1,807	6,581	8,056	10,854	12,525	15,723	11,455	10,993	10,657
Receivables	351	452	650	699	825	966	1,019	1,350	1,764	1,840	2,382	4,580	5,384	5,457	4,925	6,047	6,479	8,729	9,687	11,888	12,164	13,181	17,631	19,617	21,742	24,431	27,276	35,227	36,469	39,779
Inventory	2,328	2,882	3,190	3,446	3,558	3,919	4,014	4,017	5,454	5,720	7,109	8,008	9,153	10,343	10,695	10,046	11,032	11,045	11,930	14,001	14,760	15,296	16,450	17,516	18,496	17,760	19,090	18,025	18,107	19,246
Property, Plant & Equipment	–	–	–	–	1,742	1,847	2,216	2,542	3,506	3,953	5,334	5,853	8,125	7,923	8,322	8,467	8,632	8,615	8,843	9,855	10,175	10,292	11,349	32,904	12,606	12,896	12,873	30,435	28,937	28,056
Goodwill	–	–	725	707	819	827	879	889	1,899	1,790	3,195	23,922	25,494	25,680	25,669	26,458	26,395	26,542	28,142	38,106	38,249	38,451	78,678	79,749	79,552	79,121	78,150	91,272	91,272	85,478
Intangible Assets	722	712	725	707	819	1,193	1,230	1,293	2,766	2,592	1,318	10,430	10,446	10,127	9,784	9,869	9,753	9,529	9,774	13,878	13,511	13,630	36,524	33,121	31,142	29,026	24,803	29,234	27,323	25,508
Total Liabilities	3,497	3,364	3,575	3,596	3,645	4,069	4,448	4,521	7,560	6,952	10,657	23,400	26,386	25,873	24,435	26,492	28,568	33,588	36,224	55,234	57,628	57,436	137,913	158,279	161,014	157,618	156,506	173,092	177,485	185,682
Current Liabilities	2,123	2,911	3,133	2,890	2,964	3,065	3,106	3,489	4,859	4,584	7,005	10,766	13,490	12,300	11,070	11,956	14,150	15,425	19,027	23,169	26,250	30,648	44,009	53,303	62,017	67,807	69,421	79,189	84,609	88,692
Short-Term Debt	–	466	786	468	611	262	37	323	916	595	2,187	2,132	3,697	2,419	1,405	806	695	561	1,260	1,197	1,916	4,821	1,985	5,377	7,078	5,851	3,456	4,713	7,494	5,805
Accounts Payable	1,046	1,234	1,286	1,454	1,352	1,536	1,708	1,666	2,276	2,468	2,522	3,593	3,801	3,560	4,026	4,370	5,070	5,548	6,547	7,490	7,946	8,863	8,925	10,492	11,138	12,544	14,838	14,897	15,892	59,384
Long-Term Debt	–	–	–	–	537	810	1,076	753	1,926	1,594	2,870	8,350	8,057	8,756	8,652	9,208	9,133	12,841	11,695	26,267	25,615	22,181	71,444	64,699	59,207	51,971	50,476	58,638	60,527	60,502
Shareholders' Equity	2,196	2,615	3,111	3,680	4,305	4,567	5,197	6,022	6,987	8,331	9,918	31,322	34,574	35,768	37,700	38,051	37,653	37,938	37,958	37,196	36,830	37,691	58,225	63,864	69,389	75,075	71,469	76,461	75,560	75,214
Retained Earnings	1,588	1,727	2,021	2,544	3,185	3,493	4,104	4,847	5,646	6,739	7,967	10,287	13,098	16,355	19,303	22,090	24,998	28,493	31,849	35,506	38,983	43,556	40,911	45,108	49,640	54,906	56,398	61,604	62,837	61,196
Shares Outstanding	426	791	810	818	799	797	811	808	822	842	853	1,372	1,469	1,450	1,377	1,347	1,280	1,226	1,169	1,126	1,079	1,024	1,044	1,305	1,314	1,329	1,323	1,290	1,262	1,271

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings